STAAR Surgical to Participate in Two Upcoming Investor Conferences
- None.
- None.
- Oppenheimer Healthcare MedTech & Services Conference, Tuesday, March 12
- Sidoti Small Cap Conference, Wednesday, March 13
Management will also meet with investors in
Investor participation is by invitation from each sponsoring brokerage firm.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 2,500,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240306803500/en/
Investors & Media
Brian Moore
Vice President, Investor Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com
Source: STAAR Surgical Company
FAQ
When will STAAR Surgical Company participate in the Oppenheimer Healthcare MedTech & Services Conference?
What is the ticker symbol for STAAR Surgical Company?